USC Norris Comprehensive Cancer Center
The USC Norris Preclinical Models Shared Resource (PMSR) provides consultation and support for the use of preclinical models, including patient-derived xenografts, intending to generate data to foster the development of novel drug compounds or combinations for the treatment of cancer. The PMSR will work closely with investigators and the Data Science Core to ensure the appropriate preclinical model selection and study design, conduct single or combination drug compound testing, and report preclinical activity. The PMSR will also facilitate biomarker and target validation testing in collaboration with other NCCC Core Facilities, including the Molecular Genomics Core and the Liquid Biopsy Core. These studies are likely to yield robust preliminary data for grant proposals, rationale for novel early-phase clinical trials, and enhance our competitive edge for NCI CTEP solicitations.
The main goals of PMSR are to: